Sydney Lupkin

Merck Will Help Manufacture Johnson & Johnson's COVID-19 Vaccine

Sydney Lupkin

Merck traditionally has been a leader in vaccines but has not had success with a COVID-19 vaccine. It's lending a hand to Johnson & Johnson, where production is running significantly behind schedule.

Acting FDA Commissioner Janet Woodcock said the agency would likely hold advisory panel meetings to consider changes in COVID-19 vaccines made in response to coronavirus variants.

FDA Aims To Be 'Nimble' On COVID-19 Vaccine Changes For Variants

Sydney Lupkin

The Food and Drug Administration is working on a playbook for how it could greenlight vaccine tweaks. Studies in hundreds of people, rather than tens of thousands, seem likely.

A worker carries boxes containing the Pfizer-BioNTech COVID-19 vaccine that were being prepared for shipment from a Pfizer facility in Portage, Mich., in December.

Moderna Increases COVID-19 Vaccine Shipments While Pfizer Lags Behind

Sydney Lupkin

The two companies producing COVID-19 vaccines for use in the United States will have to raise production to meet contractual goals of 100 million doses each by the end of March.

A COVID-19 vaccine hub taking appointments only stands in Brooklyn as New York City begins to run low on doses Friday.

Moderna And Pfizer Need To Nearly Double COVID-19 Vaccine Deliveries To Meet Goals

Sydney Lupkin

The two companies making COVID-19 vaccines each promised to deliver 100 million doses to the federal government by the end of March. So far, they appear to be running behind.

People line up on Thursday for the first day of Clark County's pilot COVID-19 vaccination program at Cashman Center in Las Vegas.

COVID-19 Supply Deal Lets Vaccine Maker Earmark Doses For Employees And Their Families

Sydney Lupkin

Emergent BioSolutions is under contract with Operation Warp Speed to make COVID-19 vaccines, but the terms could allow employees and their families to get vaccinated ahead of schedule.

A worker passes through the security gate at the Moderna campus in Norwood, Mass., one of the sites where the biotechnology company is manufacturing its COVID-19 vaccine.

How Will Moderna Meet The Demand For Its COVID-19 Vaccine?

Sydney Lupkin

Despite being founded a decade ago, Moderna has never had a product make it to market. And the company registered its first factory with the Food and Drug Administration just this week.

A vial of the COVID-19 vaccine developed by Pfizer and BioNTech that was used at the Royal Victoria Hospital in Belfast, U.K., on Tuesday.

U.S. Government May Find It Hard To Get More Doses Of Pfizer's COVID-19 Vaccine

Sydney Lupkin

A Pfizer board member says the government declined to buy more doses beyond the initial 100 million already agreed upon. Demand from other countries could complicate future purchases.

Refrigerators store Pfizer's COVID-19 vaccine at a company facility in Kalamazoo, Mich.

Pfizer's Coronavirus Vaccine Supply Contract Excludes Many Taxpayer Protections

Sydney Lupkin

The $1.95 billion Operation Warp Speed contract excludes government rights to inventions or production know-how developed in the manufacture of the COVID-19 vaccine.

Novavax released its federal contract to develop and supply a COVID-19 vaccine. The agreement reveals terms that weren't previously known.

Novavax Posts Coronavirus Vaccine Contract That Government Didn't Disclose

Sydney Lupkin

The $1.6 billion Novavax contract is one of several Operation Warp Speed agreements issued through a third party, Advanced Technology International, and that hadn't been released.

The Department of Health and Human Services on Saturday made public several contracts with companies working on COVID-19 vaccines as part of Operation Warp Speed.

HHS Released More Coronavirus Vaccine Contracts As Election Results Unfolded

Sydney Lupkin

Newly released COVID-19 vaccine contracts include weakened protections against potential price gouging. Several key federal contracts still haven't been disclosed by the government.